Purified anti-human G-CSF Antibody anti-G-CSF - BVD13-3A5,BioLegend,502101

ELISA or ELISPOT Capture1,2:The purified BVD13-3A5 antibody is useful as the capture antibody in a sandwich ELISA or ELISPOT assay, when used in conjunction with the biotinylated BVD11-37G10 antibody (Cat. No. 506702) as the detecting antibody. The LEAF™ purified antibody is suggested for ELISPOT capture.

Host

Rat

Reactivity

Human

Application

ELISA Capture - Quality testedIHC - Reported in the literature, not verified in house

Platform ID

BAB149828721

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-human G-CSF Antibody anti-G-CSF - BVD13-3A5
Cat. No.502101
HostRat
RRIDAB_315207 (BioLegend Cat. No. 502101)AB_2083733 (BioLegend Cat. No. 502102)
IsotypeRat IgG1, κ
ReactivityHuman
ApplicationELISA Capture - Quality testedIHC - Reported in the literature, not verified in house
ClonalityMonoclonal
Clone NumberBVD13-3A5
Concentration0.5 mg/ml
TargetG-CSF
ImmunogenE. coli-expressed, recombinant human G-CSF
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Granulocyte - colony stimulating factor (G-CSF) is a potent stimulator of bone marrow cells especially those of neutrophilic granulocyte lineage. In addition, G-CSF can enhance the survival and activate the immunological functions of mature neutrophils. G-CSF is produced primarily by monocytes and macrophages upon activation by endotoxin, TNF-alpha or IFN-gamma.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.